| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Zevra Therapeutics Q3 2024 Earnings Preview
|
| Nov 11 |
Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 11 |
Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
|
| Nov 6 |
Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13
|
| Oct 31 |
Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024
|
| Oct 30 |
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
| Oct 29 |
Earnings Preview: Zevra Therapeutics (ZVRA) Q3 Earnings Expected to Decline
|
| Oct 10 |
Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
|
| Oct 9 |
Zevra Therapeutics Inc (ZVRA) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid ...
|
